# Efficacy of 5-fluorouracil and Low Molecular Weight Heparin in High-risk Pediatric Retinal Detachment

> **NCT06166914** · NA · COMPLETED · sponsor: **Alexandria University** · enrollment: 42 (actual)

## Conditions studied

- Retinal Detachment
- Proliferative Vitreoretinopathy

## Interventions

- **DRUG:** Intraoperative infusion of 5-FU (200 µg/ml) and LMWH (5 IU/ml)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06166914
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-21
- **Primary completion:** 2022-10-21
- **Final completion:** 2023-05-21
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2023-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06166914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06166914, "Efficacy of 5-fluorouracil and Low Molecular Weight Heparin in High-risk Pediatric Retinal Detachment". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06166914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*